Skip to main content

Advertisement

Log in

Periappendicitis during adalimumab treatment for ileocecal Crohn’s disease in a 29-year-old male

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

A 29-year-old male was diagnosed with ileocolic Crohn’s disease (CD) approximately 2 years ago. Adalimumab was prescribed as CD remission induction therapy. Three months after beginning adalimumab, watery diarrhea and lower abdominal pain developed. He was admitted under a diagnosis of CD exacerbation. Despite fasting and antibiotic treatment, symptoms of acute panperitonitis appeared. He was diagnosed as acute appendicitis and we performed emergency surgery for peritoneal drainage and ileocecal resection on the fifth hospital day. We diagnosed periappendicitis based on the operative findings. This is the first report of periappendicitis with CD during adalimumab treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Abraham C, Cho JH. Inflammatory bowel disease. Engl J Med. 2009;361:2066–78.

    Article  CAS  Google Scholar 

  2. Colombel JF, Rutgeerts PJ, Sandborn WJ, et al. Adalimumab induces deep remission in patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2014;12(414–22):e5.

    PubMed  Google Scholar 

  3. Mandel MD, Miheller P, Mullner K, et al. Have biologics changed the natural history of Crohn’s disease? Dig Dis (Basel Switz). 2014;32:351–9.

    Article  Google Scholar 

  4. Watanabe M, Hibi T, Mostafa NM, et al. Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn’s disease. J Crohn’s Colitis 2014.

  5. Fink AS, Kosakowski CA, Hiatt JR, Cochran AJ. Periappendicitis is a significant clinical finding. Am J Surg. 1990;159:564–8.

    Article  CAS  PubMed  Google Scholar 

  6. Chaudhary P, Nabi I, Arora MP. Periappendicitis: our 13 year experience. Int J Surg (Lond Engl). 2014;12:1010–3.

    Article  Google Scholar 

  7. O’Neil MB, Moore DB. Periappendicitis: clinical reality or pathologic curiosity? Am J Surg. 1977;134:356–7.

    Article  PubMed  Google Scholar 

  8. Mukherjee A, Schlenker E, LaMasters T, et al. Periappendicitis: is it a clinical entity? Am Surg. 2002;68:913–6.

    PubMed  Google Scholar 

  9. Savarino E, Bodini G, Dulbecco P, et al. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial. Am J Gastroenterol. 2013;108:1731–42.

    Article  CAS  PubMed  Google Scholar 

  10. Syed A, Cross RK, Flasar MH. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn’s disease patients. Am J Gastroenterol. 2013;108:583–93.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosures

Conflict of Interest: All authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shinta Mizuno.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mizuno, S., Nakazawa, A., Ogawa, A. et al. Periappendicitis during adalimumab treatment for ileocecal Crohn’s disease in a 29-year-old male. Clin J Gastroenterol 8, 134–137 (2015). https://doi.org/10.1007/s12328-015-0575-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-015-0575-x

Keywords

Navigation